Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Title
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 376, Issue 2, Pages 125-135
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2017-01-12
DOI
10.1056/nejmoa1607427

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now